Menu
Recruiting NCT07227038

Living Well With Advanced Breast Cancer

— Observational Advanced Breast Carcinoma Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Advanced Breast Carcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.

Detailed description

PRIMARY OBJECTIVES:

I. Assess acceptability of current LWABC model. II. Conduct a comprehensive review of participants' medical history, treatment records, and demographic data.

III. Explore differences in survivorship care engagement across four distinct cohorts.

OUTLINE: This is an observational study.

Participants complete a survey and a semi-structured interview on study.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Acceptability of current LWABC (Living Well with Advanced Breast Cancer) model [Time frame: Up to study completion, up to 1 day]
  • Participant medical history, treatment records, and demographic data [Time frame: Up to study completion, up to 1 day]
  • Differences in survivorship care engagement across four distinct cohorts [Time frame: Up to study completion, up to 1 day]

Eligibility criteria

Inclusion criteria

  • \* COHORT 1:
  • Diagnosis of stage 4 metastatic breast cancer within the past 5 years
  • Never been referred to the LWABC
  • Adults age ≥ 18 years
  • COHORT 2:
  • Diagnosis of stage 4 metastatic breast cancer within the past 5 years
  • Have cancelled an appointment with the LWABC
  • Adults age ≥ 18 years
  • COHORT 3:
  • Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years
  • Completed an appointment with the LWABC
  • Adults age ≥ 18 years
  • COHORT 4:
  • Caregivers for ABC patients
  • Adults age ≥ 18 years

Exclusion criteria

  • Patients who cannot provide own informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Ohio State University Comprehensive Cancer Center — Columbus

Identifiers

NCT: NCT07227038 · OSU-24331 · NCI-2025-08030

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗